1. Home
  2. VREX vs LRMR Comparison

VREX vs LRMR Comparison

Compare VREX & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$10.98

Market Cap

447.2M

Sector

Technology

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
LRMR
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.2M
455.8M
IPO Year
2016
2014

Fundamental Metrics

Financial Performance
Metric
VREX
LRMR
Price
$10.98
$4.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.67
$16.50
AVG Volume (30 Days)
466.3K
2.6M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$811,000,000.00
N/A
Revenue This Year
$5.35
N/A
Revenue Next Year
$3.88
$1,816.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$2.72
52 Week High
$14.57
$6.42

Technical Indicators

Market Signals
Indicator
VREX
LRMR
Relative Strength Index (RSI) 57.73 60.14
Support Level $10.88 $3.87
Resistance Level $12.62 $4.32
Average True Range (ATR) 0.47 0.28
MACD 0.01 0.04
Stochastic Oscillator 80.33 78.83

Price Performance

Historical Comparison
VREX
LRMR

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: